scispace - formally typeset
M

Maria A. Rocca

Researcher at Vita-Salute San Raffaele University

Publications -  647
Citations -  29881

Maria A. Rocca is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Multiple sclerosis & Magnetic resonance imaging. The author has an hindex of 83, co-authored 556 publications receiving 25283 citations. Previous affiliations of Maria A. Rocca include University at Buffalo & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage.

TL;DR: Cervical cord average FA was significantly reduced in MS patients with RLS compared to those without, and higher disability and cervical cord damage represent a significant risk factor for RLS in multiple sclerosis patients.
Journal ArticleDOI

Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.

TL;DR: Distinct patterns of regional distribution of GM damage and T2‐visible lesions are associated with cognitive impairment in MS patients with different clinical phenotypes, and the correspondence between lesion formation and GM atrophy distribution varies in the different forms of MS.
Journal ArticleDOI

Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.

TL;DR: Lesions in strategic brain WM tracts contribute to cognitive impairment in MS through a multisystem disconnection syndrome via conventional and diffusion tensor MRI tractography.
Journal Article

Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis.

TL;DR: This preliminary 3-year follow-up study shows that newly enhancing lesions and normal-appearing white matter in patients with secondary progressive MS have significantly lower MTR values than do those in patientswith relapsing-remitting MS and that the tissue damage that remains after enhancement ceases is more severe in secondary progressive disease.